Lots of CRO deals lately. Now Evotec, a Germany-based vendor focusing on pre-clinical development, is acquiring Aptuit, which provides similar services, for $300 million.
This is what happens when you don't have a fruit in your company name, you get sold. Nursing home pharmacy chain Pharmerica is being bought by a PE firm for $1.4 billion. No word yet on whether the name will be changed to Pharnana.
Must be a fruity day, as Limelight Health garners $7 million in new funding for its employee health benefits enrollment, etc. software. What's next--a company named Apple?
In a nutty idea, chronic disease prevention firm Fruit Street has raised $8 million, mostly from physicians, which should be a tipoff to other investors (physicians are legendary for the investing acumen (not)).
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.